4[1]De Bruijm SFTM, Stam J. For the cerebral venous sinus thrombosis study group. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebr-al sinus thrombosis[ J]. Stroke,1999,30:484 ～ 488.
5[2]Wingerchuk DM, Wijdicks EFM, Fulgnam JR. Cerebral venous thrombosis complicated by hemorrhagic infarction: factors affe-cting the initiation and safety of anticoagulation[ J]. Cerebrovasc Dis, 1998,8:25 ～ 30.
7[4]Stolz E, Gerriets T, Bodeker RH, et al. Intracranial, is a factor related to a favorable outcome in cerebral venous thrombosis [ J ]. Stroke, 2002, 33:1645～ 1650.
8[5]Chu K, Kang DW, Yoon BW, et al. Diffusion weighted magnetic resonance in cerebral venous thrombosis[J]. Arch Neurol,2001,58:1569 ～ 1576.
9Wasay M,Bakshi R,Kojan S,et al.Nonrandomized comparison of local urokinase thrombolysis versus systemic heparin.anticoagulation for superior sagittal sinus thrombosis.Stroke,2001,32:2310-2317.
10Singh T,Chakera T.Dural sinus thrombosis presenting as unilateral lobar haematomas with mass effect:an easily misdiagnosed cause of cerebral haemorrhage.Australas Radiol,2002,46:351-365.
